Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2281–2304 of 7,487 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Control Clear all

Conditions: Stress
Interventions: Single consent; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 333 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Obesity
Interventions: Behavioral weight loss therapy, Portion-controlled meals, Acceptance-based treatment; Behavioral
Lead sponsor: HealthPartners Institute; Other
Eligibility: 21 Years to 70 Years
Enrollment: 468 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Bloomington, Minnesota

Conditions: Diabetic Foot Ulcers (DFUs), Diabetic Foot, Chronic Wounds
Interventions: Miro3D Wound Matrix, Standard of Care; Device · Other
Lead sponsor: Reprise Biomedical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 14
States / cities: Phoenix, Arizona • Coconut Creek, Florida • Coral Gables, Florida + 9 more

Conditions: Gastroparesis
Interventions: Gastric endoscopic peroral pyloromyotomy, Esophago-gastro-duodenoscopy; Procedure
Lead sponsor: Institute for Clinical and Experimental Medicine; Government
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Postoperative Pain, Inflammation, Osteoarthritis
Interventions: Dexamethasone 10 mg, Dexamethasone 20 mg, Standard multimodal pain management regimen, Placebo; Drug
Lead sponsor: Thomas L Bradbury; Other
Eligibility: 18 Years to 100 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Tucker, Georgia

Conditions: Spinal Stenosis
Interventions: CBPT, Control-Attention; Behavioral · Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 21 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Squamous Cell Carcinoma, Non-Small-Cell Lung
Interventions: Abraxane (Induction), Carboplatin (Induction), Abraxane (Maintenance), Best Supportive Care (Maintenance); Drug · Other
Lead sponsor: Celgene; Industry
Eligibility: 18 Years and older
Enrollment: 427 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 91
States / cities: Huntsville, Alabama • Glendale, Arizona • Tucson, Arizona + 73 more

Conditions: Chagas Disease
Interventions: LXE408, Placebo, Benznidazole; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 4
States / cities: Sylmar, California • Gainesville, Florida • Boston, Massachusetts + 1 more

Conditions: Full Thickness Rotator Cuff Tear, Rotator Cuff Tendinitis
Interventions: Ketorolac, Marcaine (placebo), Kenalog; Drug
Lead sponsor: Michael Khazzam; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 2
States / cities: Baltimore, Maryland • Dallas, Texas

Conditions: Cerebral Palsy, Muscle Spasticity
Interventions: Low-magnitude vibration, Botox; Device · Drug
Lead sponsor: University of Delaware; Other
Eligibility: 2 Years to 12 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Newark, Delaware • Wilmington, Delaware

Conditions: Death, Sudden, Cardiac, Ventricular Fibrillation, Tachycardia, Ventricular
Interventions: Defibrillation of pulseless VT/VF by AECD; Device
Lead sponsor: Foundation for Atlanta Veterans Education and Research, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Chronic Hepatitis B
Interventions: ABI-H0731, Placebo, NrtI; Drug
Lead sponsor: Assembly Biosciences; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 9
States / cities: Los Angeles, California • Pasadena, California • San Diego, California + 6 more

Conditions: Colorectal Neoplasms
Interventions: Standard Information, Preference-tailored Information; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 50 Years to 78 Years
Enrollment: 466 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Pittsburgh, Pennsylvania

Conditions: Asthma
Interventions: Environmental Intervention; Other
Lead sponsor: Columbia University; Other
Eligibility: 6 Years and older
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: New York, New York • The Bronx, New York

Conditions: Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: sunitinib malate, cognitive assessment; Drug · Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 3
States / cities: Detroit, Michigan • Cleveland, Ohio

Conditions: Diabetic Foot
Interventions: SkinTE, Control; Biological · Other
Lead sponsor: PolarityTE; Industry
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 13
States / cities: Fresno, California • Los Angeles, California • Hollywood, Florida + 8 more

Conditions: Post Operative Pain
Interventions: Pain and standard side effect management for PNCA with basal method., Pain and standard side effect management with PNCA without basal, Pain and standard side effect management with IV on an as needed basis method.; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 4 Years to 18 Years
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Laparoscopic Adnexal Surgery
Interventions: Normal Saline (0.9% NaCl), Marcaine hydrochloride without epinephrine 0.5%; Other · Drug
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years and older · Female only
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Pancreatitis, Chronic, Pancreatitis, Acute Recurrent
Interventions: Internet-based CBT intervention; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Asthma
Interventions: Asthma Express Intervention, Standard Asthma Education Control Group; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 3 Years to 12 Years
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chronic Low Back Pain
Interventions: Enhanced facilitation of COPES; Behavioral
Lead sponsor: VA Connecticut Healthcare System; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 3
States / cities: Menlo Park, California • Indianapolis, Indiana • Brockton, Massachusetts

Conditions: Aging, Healthy Aging
Interventions: Strawberry, Placebo group; Other
Lead sponsor: San Diego State University; Other
Eligibility: 65 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: Asthma, Pneumonia, Bronchiolitis
Interventions: Multi-condition Pathway Intervention; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: Up to 17 Years
Enrollment: 11,760 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Lung Cancer, Pulmonary Neoplasm, Neoplasms, Lung, Neoplasms, Pulmonary, Neoplasm, Pulmonary, Cancer, Lung, Cancers, Lung, Pulmonary Cancer, Cancer, Pulmonary, Cancers, Pulmonary, Pulmonary Cancers, Cancer of the Lung, Cancer of Lung, Pulmonary Neoplasms, Lung Cancers
Interventions: Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program, Enhanced Usual Care; Behavioral
Lead sponsor: Jerod L Stapleton, PhD; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Lexington, Kentucky

Search by objective public record fields.

Bundle Consent and Expectation Setting in Pediatric Intensive Care Unit

BestFIT: a Personalized Weight Loss Program

Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers

Endoscopic Pyloromyotomy for Refractory Gastroparesis

Steroids in Total Knee Arthroplasty

Cognitive-Behavioral Physical Therapy

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.

Effectiveness of Corticosteroid vs. Ketorolac Shoulder Injections: A Prospective Double-Blinded Randomized Trial

Effect of Botox and Vibration on Bone in Children With Cerebral Palsy

Automatic External Defibrillation Monitoring in Cardiac Arrest

A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase Inhibitors

Evaluating a Preference-based Intervention for Increasing Colorectal Cancer Screening

Environmental Intervention Versus Standard Care to Reduce Pharmacologic Therapy for Asthma

Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs

Parent Nurse Controlled Analgesic in Pediatric Patients With Developmental Delay

Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery

Internet-based Pain Self-management for Persons With Acute Recurrent and Chronic Pancreatitis Pain

Asthma Express: Bridging the Emergency to Primary Care in Underserved Children

Cooperative Pain Education and Self-management

Strawberries, Cognition, and Vascular Health

Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children

Precision Lung Cancer Survivorship Care Intervention